<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Tata Consultancy Services Limited

NSE: TCS · Lot size: 175

Tata Consultancy Services Limited Open Interest & PCR Analysis

2,604.4Updated 21 Apr 2026, 01:26 pm IST
PCR
0.63
Bearish signal
Max Pain
2,540
Spot above by ₹64
Total CE OI
16.57M
Call writers
Total PE OI
10.51M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-18

Frequently Asked Questions

What is Tata Consultancy Services Limited PCR (Put-Call Ratio) today?
Tata Consultancy Services Limited's current PCR is 0.63. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Tata Consultancy Services Limited's PCR of 0.63 indicates bearish sentiment.
What is Tata Consultancy Services Limited OI buildup type today?
Tata Consultancy Services Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Tata Consultancy Services Limited?
Tata Consultancy Services Limited has total CE (call) OI of 16570750 contracts and total PE (put) OI of 10511550 contracts for the nearest expiry. The PCR is 0.63.
How is open interest analysis useful for Tata Consultancy Services Limited trading?
OI analysis for Tata Consultancy Services Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Tata Consultancy Services Limited?
Tata Consultancy Services Limited's max pain is ₹2,540 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.